METASTATIC COLORECTAL ADENOCARCINOMA
Clinical trials for METASTATIC COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced pancreatic and colorectal cancers
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial is testing a personalized peptide vaccine made from a patient's own tumor cells and blood. The goal is to see if it's safe and feasible for people with advanced pancreatic or colorectal cancer that has spread. The vaccine is designed to help the immune syst…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 16, 2026 23:46 UTC
-
Fasting diet and vitamin c join forces with immunotherapy to fight tough colorectal cancer
Disease control Recruiting nowThis early-phase study is testing whether combining two immunotherapy drugs (botensilimab and balstilimab) with a special low-sugar, low-calorie diet and high-dose vitamin C is safe and tolerable for people with a specific type of advanced colorectal cancer (KRAS-mutant). About 1…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 16, 2026 23:52 UTC
-
New hope for stage IV colorectal cancer: can zapping tumors boost survival?
Disease control Recruiting nowThis study is for people with colorectal cancer that has spread to up to 4 places in the body. It compares standard drug therapy alone versus standard therapy plus targeted treatments like precise radiation, surgery, or heat ablation to destroy those cancer spots. The goal is to …
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
Radio waves plus targeted drug tested in tough-to-treat colon cancer
Disease control Recruiting nowThis study tests whether adding a device that delivers low-level radiofrequency electromagnetic fields (AM RF EMF) to the targeted drug fruquintinib can help people with metastatic colorectal cancer live longer. The treatment is for patients whose cancer has not responded to or s…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New drug combo targets Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis study is for people with advanced colorectal cancer that has stopped responding to standard treatments. It tests a combination of two drugs: pidnarulex, which blocks enzymes that help cancer cells grow, and cemiplimab, an immunotherapy that helps the immune system attack the…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New combo drug trial hopes to shrink tough cancers
Disease control Recruiting nowThis early-stage study tests a new combination of two drugs (trifluridine/tipiracil and talazoparib) in people with advanced colorectal or gastroesophageal cancers that have spread. The main goals are to find the safest dose and understand side effects. About 45 participants will…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cancer pill shows promise in early trial for advanced tumors
Disease control Recruiting nowThis study tests a new cancer pill (PF-08032562) in people with advanced breast or colorectal cancer that has spread. The goal is to find the safest dose and see how well it works alone or with other treatments. About 260 adults will take the pill daily in 28-day cycles, with som…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New drug combo aims to boost colorectal cancer treatment
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug CA-4948 to standard chemotherapy (FOLFOX) and a blood-vessel blocker (bevacizumab) is safe and tolerable for people with colorectal cancer that has spread. About 24 adults with advanced disease will receive the com…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:17 UTC